Corey McCann, departing Pear Therapeutics CEO

Dig­i­tal ther­a­peu­tics mak­er Pear files for bank­rupt­cy, lays off 170 staffers — in­clud­ing CEO

Less than a month af­ter say­ing it will em­bark on a search for strate­gic al­ter­na­tives, Pear Ther­a­peu­tics de­cid­ed to go the bank­rupt­cy route and filed for Chap­ter 11 pro­tec­tion.

Al­most all of its em­ploy­ees — 170 peo­ple in to­tal, or 92% — are be­ing let go, in­clud­ing CEO Corey Mc­Cann, the com­pa­ny dis­closed in an SEC fil­ing. The re­main­ing 15 will be tasked with look­ing for and com­plet­ing deals to sell ei­ther the whole busi­ness or parts of it, un­der the su­per­vi­sion of the court.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.